Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iopamidol vs Iodixanol in High-Risk Patients
NCT01402219Phase 4Terminated
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2008
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iopamidol in coronary artery disease (CAD), sponsored by Guangdong Provincial People's Hospital. Started Nov 2008; status: terminated.
02
Drugs
iopamidol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01402219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402219.